A need for basic research on fluid-based early detection biomarkers

Cancer Research

Volumn 70, Issue 13, 2010, Pages 5203-5206

  Martin, Katherine J ^a   Fournier, Marcia V ^a   Veer Reddy, G Prem ^b   Pardee, Arthur B ^c  

^a Bioarray Therapeutics Inc   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA; NUCLEIC ACID; PROSTATE SPECIFIC ANTIGEN; RNA; TUMOR MARKER;

BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RESEARCH; CANCER SURVIVAL; COLON CANCER; HUMAN; LEUKEMIA; LYMPHOMA; METASTASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; TESTIS CANCER;

EARLY DIAGNOSIS; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954381942     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0987     Document Type: Review

References (23)

1. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
2. American Cancer Society. Cancer Facts & Figures. Atlanta: American Cancer Society; 2009.
3. Marshall E. Public health. Brawling over mammography. Science 2010;327:936-8.
4. Martin KJ, Graner E, Li Y, et al. High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci U S A 2001; 98:2646-51.
5. Showe MK, Vachani A, Kossenkov AV, et al. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 2009;69:9202-10.
6. Critchley-Thorne RJ, Yan N, Nacu S, Weber J, Holmes SP, Lee PP. Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. PLoS Med 2007;4:e176.
7. Osman I, Bajorin DF, Sun TT, et al. Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res 2006;12:3374-80. (Pubitemid 43910882)
8. Sharma P, Sahni NS, Tibshirani R, et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res 2005;7:R634-44.
9. Twine NC, Stover JA, Marshall B, et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 2003;63:6069-75. (Pubitemid 37187512)
10. Kaiser J. Medicine. Cancer's circulation problem. Science 2010;327: 1072-4.
11. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009;6:339-51.
12. Swaminathan R, Butt AN. Circulating nucleic acids in plasma and serum: recent developments. Ann NY Acad Sci 2006;1075:1-9. (Pubitemid 44532759)
13. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 1997;278:1054-9. (Pubitemid 27517874)
14. Schmidt K, Diehl F. A blood-based DNA test for colorectal cancer screening. Discov Med 2007;7:7-12.
15. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-8.
16. Sunami E, Vu AT, Nguyen SL, Hoon DS. Analysis of methylated circulating DNA in cancer patients' blood. Methods Mol Biol 2009; 507:349-56.
17. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007;1775:181-232.
18. Bai VU, Kaseb A, Tejwani S, et al. Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Proc Natl Acad Sci U S A 2007; 104:2343-8.
19. Lee JM, Garon E, Wong DT. Salivary diagnostics. Orthod Craniofac Res 2009;12:206-11.
20. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18.
21. Coates RJ, Kolor K, Stewart SL, Richardson LC. Diagnostic markers for ovarian cancer screening: not ready for routine clinical use. Clin Cancer Res 2008;14:7575-6, author reply 7-9.
22. Ransohoff DF. Promises and limitations of biomarkers. Recent Results Cancer Res 2009;181:55-9.
23. Dalton WS, Friend SH. Cancer biomarkers-an invitation to the table. Science 2006;312:1165-8.